Novel steroidal 1,3,4-thiadiazines: Synthesis and biological evaluation in androgen receptor-positive prostate cancer 22Rv1 cells Full article
| Journal |
Bioorganic Chemistry
ISSN: 1090-2120 , E-ISSN: 0045-2068 |
||||||
|---|---|---|---|---|---|---|---|
| Output data | Year: 2019, Volume: 91, Article number : 103142, Pages count : DOI: 10.1016/j.bioorg.2019.103142 | ||||||
| Authors |
|
||||||
| Affiliations |
|
Abstract:
A flexible approach to previously unknown spirofused and linked 1,3,4-thiadiazine derivatives of steroids with selective control of heterocyclization patterns is disclosed. (N-Arylcarbamoyl)spiroandrostene-17,6′ [1,3,4]thiadiazines and (N-arylcarbamoyl)17-[1′,3′,4′]thiadiazine-substituted androstenes, novel types of heterosteroids, were prepared from 16β,17β-epoxypregnenolone and 21-bromopregna-5,16-dien-20-one in good to high yields by the treatment with oxamic acid thiohydrazides. The synthesized compounds were screened for antiproliferative activity against the human androgen receptor-positive prostate cancer cell line 22Rv1. Most of (N-arylcarbamoyl)17-[1′,3′,4′]thiadiazine-substituted androstenes exhibit better antiproliferative potency (IC50 = 2.1–6.6 µM) than the antiandrogen bicalutamide. Compounds 7d with IC50 = 3.0 μM and 7j with IC50 = 2.1 μM proved to be the most active in the series under study. Lead synthesized compound 7j downregulates AR expression and activity in 22Rv1 cells. NF-κB activity is also blocked in 7j-treated 22Rv1 cells. Apoptosis is considered as a possible mechanism of 7j-induced cell death.
Cite:
Komendantova A.S.
, Scherbakov A.M.
, Komkov A.V.
, Chertkova V.V.
, Gudovanniy A.O.
, Chernoburova E.I.
, Sorokin D.V.
, Dzichenka Y.U.
, Shirinian V.Z.
, Volkova Y.A.
, Zavarzin I.V.
Novel steroidal 1,3,4-thiadiazines: Synthesis and biological evaluation in androgen receptor-positive prostate cancer 22Rv1 cells
Bioorganic Chemistry. 2019. V.91. 103142 . DOI: 10.1016/j.bioorg.2019.103142 WOS Scopus OpenAlex
Novel steroidal 1,3,4-thiadiazines: Synthesis and biological evaluation in androgen receptor-positive prostate cancer 22Rv1 cells
Bioorganic Chemistry. 2019. V.91. 103142 . DOI: 10.1016/j.bioorg.2019.103142 WOS Scopus OpenAlex
Identifiers:
| Web of science: | WOS:000487812000039 |
| Scopus: | 2-s2.0-85070209453 |
| OpenAlex: | W2963913257 |